Stay updated on Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Sign up to get notified when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.

Latest updates to the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of vibegron for treating irritable bowel syndrome, while a new version number has been added.SummaryDifference14%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.